Menu Search
Equities

Gushengtang Holdings Ltd

F2P:FRA

Gushengtang Holdings Ltd

Actions
  • Price (EUR)4.04
  • Today's Change0.02 / 0.50%
  • Shares traded--
  • 1 Year change-30.34%
  • Beta--
Data delayed at least 15 minutes, as of Jul 26 2024 14:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Gushengtang Holdings Ltd is a China-based company mainly engaged in traditional Chinese medicine (TCM) medical and health services. The Company operates in two segments. Medical and Health Solutions segment is engaged in providing customers with traditional Chinese medical and health services through offline medical institutions and online medical and health platforms, including consultation, diagnosis, prescription services, decoctions and physical therapy. Sales of Medical and Health Products segment is mainly responsible for the sales of related products. The Company's main products include Ejiao, Cordyceps, cubilose, dendrobium, American Ginseng and other medicinal materials. The Company also provides honey, Ejiao cake and other nutritional products.

  • Revenue in HKD (TTM)2.51bn
  • Net income in HKD272.27m
  • Incorporated2014
  • Employees2.66k
  • Location
    Gushengtang Holdings LtdNo. 761 Dongfeng East RoadUnit 01-04, 36 Floor, Lifeng CentreGUANGZHOU ChinaCHN
  • Websitehttps://www2.gstzy.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.